Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554855-25-002032
Filing Date
2025-11-13
Accepted
2025-11-13 13:31:01
Documents
68
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sxtp-20250930.htm   iXBRL 10-Q 2084993
7 EXHIBIT 31.1 ex311_1.htm EX-31.1 13766
8 EXHIBIT 31.2 ex312_2.htm EX-31.2 13595
9 EXHIBIT 32.1 ex321_3.htm EX-32.1 5679
10 EXHIBIT 32.2 ex322_4.htm EX-32.2 5483
  Complete submission text file 0001554855-25-002032.txt   9353983

Data Files

Seq Description Document Type Size
2 DEFINITION sxtp-20250930_def.xml EX-101.DEF 333126
3 PRESENTATION sxtp-20250930_pre.xml EX-101.PRE 499621
4 CALCULATION sxtp-20250930_cal.xml EX-101.CAL 87023
5 LABEL sxtp-20250930_lab.xml EX-101.LAB 954738
6 SCHEMA sxtp-20250930.xsd EX-101.SCH 66784
71 EXTRACTED XBRL INSTANCE DOCUMENT sxtp-20250930_htm.xml XML 1379962
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

EIN.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41719 | Film No.: 251477100
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)